Whole-Body Vibration in Parkinson Disease

Summary

The aim of this study is to evaluate the effects of different frequencies of Whole Body Vibration (WBV) application on balance, gait, cognitive functions, and dual-task performance in patients with Parkinson's disease.

Study Hypotheses:

H0.1 - There is no effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease.

H1.1 - There is an effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease.

H0.2 - There is no effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease.

H1.2 - There is an effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease.

H0.3 - There is no effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease.

H1.3 - There is an effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease.

H0.4 - There is no effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease.

H1.4 - There is an effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease.

H0.5 - There is no effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease.

H1.5 - There is an effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease.

H0.6 - There is no significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease.

H1.6 - There is a significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease.

H0.7 - There is no significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease.

H1.7 - There is a significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease.

H0.8 - There is no significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease.

H1.8 - There is a significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease.

H0.9 - There is no significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease.

H1.9 - There is a significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease.

H0.10 - There is no significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease.

H1.10 - There is a significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease.

Conditions

• Parkinson's Disease
• Balance
• Gait
• Cognitive Function
• Dual-Task Performance
• Reaction Time

Interventions

BEHAVIORAL

Functional Exercise Based Physiotherapy

A supervised functional exercise-based physiotherapy program will be conducted in a hospital setting twice per week for 8 weeks.

DEVICE

Low-Frequency Whole-Body Vibration Therapy

Whole-Body Vibration (WBV) will be applied as an adjunct to the functional exercise-based physiotherapy program. The intervention will be conducted in a hospital setting twice weekly for 8 weeks, with each session lasting 20 minutes. WBV will be applied to the low-frequency group at a frequency range of 3-10 Hz.

DEVICE

Medium-Frequency Whole-Body Vibration Therapy

Whole-Body Vibration (WBV) will be applied as an adjunct to the functional exercise-based physiotherapy program. The intervention will be conducted in a hospital setting twice weekly for 8 weeks, with each session lasting 20 minutes. WBV will be applied to the medium-frequency group at a frequency range of 12-20 Hz.

Sponsors & Collaborators

• Izmir Bakircay University

  lead OTHER

Principal Investigators

• Gülbin Ergin, Prof. Dr · Izmir Bakircay University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

30 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-01-20

Primary Completion

2026-12-31

Completion

2027-07-31

Countries

• Turkey (Türkiye)

Study Locations